Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, fi by United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology Free Download. Read online books at OnRead.com

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, fi

Includes bibliographical references

add to favoritesadd In favorites

do you like this book?

Advertising Download Read Online

Info about the book

Author:

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology

Series:

Unknown

ISBN:

1559637501

Rating:

4.5/5 (4)

Your rating:

0/5

Languge:

English

Users who have this book

I have the Ebook I have the Paperbook

Users who want this book

I want the Ebook I want the Paperbook

What readers are saying

What do you think? Write your own comment on this book!

write a comment

What do you think? Write your own comment on this book

Please Login or Register to write comments or use smm accounts

Write a comment

( Review will shown on site after approval )

Genre

Law / United States

if you like Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, fi try:

Other books by this author

A shot in the arm for Oregon's economy : making credit and capital more available to small buinesses : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One 4/5

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, fi 4.5/5

Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Com 4.5/5

Growth of small, residential living programs for the mentally retarded and developmentally disabled : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One H 3/5

Banking on small business : can the community development bank model serve small firms in economically depressed urban and rural communities? : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small 4.5/5

What role should fuel choice and natural gas play in meeting the energy needs of the Pacific Northwest? : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, O 4/5

Economic impact of the whiting allocation on Oregon coastal communities : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first 4.5/5

Informed consent : the role of consumer choice in improving the quality of health care : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third 5/5

Health care reform : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Portland, OR, September 1, 1993 5/5

Regulation of human tissue banks : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, October 15, 1 5/5

Buying medical technology in the dark : how national health reform can turn on the lights and promote technology innovation and cost savings : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small 4/5

Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Oppo 5/5

Suitability, direction, and funding of federal economic development assistance programs for small, timber-dependent communities in the Northwest : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Sm 4.5/5

Oregon and the information superhighway : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Portland, OR, January 3.5/5

Who's minding the baby? : quality and availability problems in child care for America's children : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hund 4.5/5

Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of t 3.5/5

Public dollars, private prerogatives : lessons from Medicare for national health reform : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third 2.5/5

School to work programs : an opportunity for Oregon to lead again : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second sess 3/5

RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Rep 5/5